Goodwin

Jacqueline Mercier

Deals
3
Latest
Jul 2026

Firm

  • Goodwin Law firm · 2026 · 3 deals
Deals by year
Jacqueline Mercier: deals by year0320252026 YTD: 3 M&A32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Jacqueline Mercier was named on, most recent first
Jul 2026 Neurimmune's royalty interest in AstraZeneca's cliramitug NeurimmuneRoyalty PharmaAsset saleLegal adviser to Royalty Pharma (acquirer)Announced250.0Pharma+1Royalty Pharma acquisition of Neurimmune's royalty interest in AstraZeneca's cliramitug
Jan 2026 PTC Therapeutics' remaining royalty on Roche's Evrysdi PTC TherapeuticsRoyalty PharmaAsset saleLegal adviser to Royalty Pharma (acquirer)Announced240.0Specialty finance and leasing+2Royalty Pharma acquisition of PTC Therapeutics' remaining royalty on Roche's Evrysdi
Jan 2026 Dark Blue Therapeutics –AmgenAcquisitionLegal adviser to Dark Blue Therapeutics (target)Completed840.0Biotech+2Amgen acquisition of Dark Blue Therapeutics

Deals where Jacqueline Mercier is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.